Bayer, Precision BioSciences in Crop Genome Modification Alliance | GenomeWeb

NEW YORK (GenomeWeb News) – Bayer CropScience, the agricultural subsidiary of Bayer, and Precision BioSciences announced today that they will collaborate on creating site-specific genome modifications in plants.

Under the deal, Bayer will have non-exclusive access to Precision Bio's Direct Nuclease Editor technology, which can be used to develop novel traits in plants, the firms said. Precision Bio also will supply Bayer with multiple DNE-engineered enzymes for use across the company's crop platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.